Senior MSL - Immunology & Rare Diseases (AU Field)

Pharming Group; Australia; Remote; AUD 120,000 - 160,000; Full time

Job summary

Pharming Australia is seeking a Senior Medical Science Liaison (MSL) to serve as a scientific expert and strategic partner across Australia. The role focuses on immunology, APDS and other PIDs, driving scientific engagement and supporting launch readiness and long-term medical strategy.

In this field-based position, you will work closely with the Country Manager and global Medical Affairs, building referral networks and improving patient outcomes through evidence generation and cross-functional

Qualifications

• Advanced degree in biomedical science required.
• Several years in Medical Affairs/MSL in biopharma.
• Experience in immunology and/or rare diseases preferred.
• Experience supporting pre-launch/launch/growth-stage products advantageous.

Responsibilities

• Engage with healthcare professionals, researchers, patient organizations, and key opinion leaders.
• Lead scientific exchange activities across immunology and related specialties.
• Identify barriers to diagnosis and strengthen referral pathways.
• Lead medical affairs projects, including investigator-initiated studies and collaborations.
• Support clinical research programs and future opportunities in Australia.

Skills

Scientific acumen

Relationship building

Stakeholder management

Presentation skills

Cross-functional influence

Project management

Adaptability

Entrepreneurial mindset

Rare disease passion

Education

Advanced biomedical degree (PhD/MD/PharmD)

Job description

Pharming Australia is seeking a Senior Medical Science Liaison (MSL) to serve as a scientific expert and strategic partner across Australia. The role focuses on immunology, APDS and other PIDs, driving scientific engagement and supporting launch readiness and long-term medical strategy.

In this field-based position, you will work closely with the Country Manager and global Medical Affairs, building referral networks and improving patient outcomes through evidence generation and cross-functional